Loading data for LNAI — first visit, this takes a few seconds.
Lunai Bioworks Inc. (LNAI)
NasdaqCM: LNAI
· Real-Time Price · USD
2.37
+0.02 (0.85%)
At close: Aug 28, 2026, 3:26 PM
The price, the headline numbers and the latest news, in one place.
Lunai Bioworks Inc. (LNAI) Stock Price, Analysis & Data
0.85% (1D)
| Bid | 1.73 |
| Market Cap | 10.38M |
| Revenue (ttm) | 20.94K |
| Net Income (ttm) | -128.28M |
| 0.32 | |
| -61.52 | |
| n/a | |
| n/a | |
| P/B (ttm) | -1.07 |
| P/S (ttm) | 495.78 |
| Earnings Date | Sep 28, 2026 |
| Ask | 2.94 |
| Volume | 35,205 |
| Avg. Volume (20D) | 973,319 |
| Open | 2.35 |
| Previous Close | 2.35 |
| Day's Range | 2.28 - 2.44 |
| 52-Week Range | 1.21 - 19.60 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About LNAI
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 7, 2018
Employees 29
Stock Exchange NasdaqCM
Ticker Symbol LNAI
Website https://www.lunaibioworks.com
Financial Performance
In 2025, Lunai Bioworks's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -178.01M, an increase of 101.31%.
Financial StatementsLunai Bioworks Inc. is scheduled to release its earnings on Sep 28, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
